-
Product Insights
China Energy Conservation Suzhou Solar PV Park
China Energy Conservation Suzhou Solar PV Park is a solar PV project located in Gansu, China. The project came online in 2020. Empower your strategies with our China Energy Conservation Suzhou Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or...
-
Product Insights
China Energy Conservation Investment Corporation-Taiyangshan Solar Park
China Energy Conservation Investment Corporation-Taiyangshan Solar Park is a solar PV project located in Ningxia, China. The project is owned by China Energy Conservation and Environmental Protection Group Co Ltd. The project came online in 2010. Empower your strategies with our China Energy Conservation Investment Corporation-Taiyangshan Solar Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – VAC-3S in Human Immunodeficiency Virus (HIV) Infections (AIDS)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VAC-3S in Human Immunodeficiency Virus (HIV) Infections (AIDS) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VAC-3S in Human Immunodeficiency Virus (HIV) Infections (AIDS)...
-
Sector Analysis
Malaysia Renewable Energy Policy Handbook, 2024 Update
"Malaysia Renewable Energy Policy Handbook 2024” is among the latest country specific policy reports from GlobalData, the industry analysis specialist. The report offers comprehensive information on major policies governing the renewable energy market in the country and provides information on renewable policies/developments at a regional/municipal level. The report discusses renewable energy targets and plans along with the present policy framework, giving a fair idea of overall growth potential of the renewable energy industry. The report also provides major technology specific...
-
Sector Analysis
Digits Replacement Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Digits Replacement Market Report Overview The Digits Replacement market was valued at $128 million in 2023. The market is expected to grow at a CAGR of more than 4% from 2023 to 2033. Digit Fusion and Digit Replacement are the two common procedures for the treatment of severe end-stage digit arthritis which is nonresponsive to conservative treatment. Although fusion is often still considered the treatment of choice the new generation digit implants have shown good results with low failure rates....
-
Sector Analysis
Automated Homes Market Size, Share, Trends, and Analysis by Device Type, Region and Segment Forecast to 2030
Accessing the in-depth insights from the ‘Automated Homes’ report can help you: Make informed decisions about market entry, technology adoption, and project planning. Identify competitors' capabilities to stay ahead in the market. Identify promising device segments, growth trends, regional trends, and markets to expand your regional presence, product portfolio, and discover successful investment opportunities. Anticipate changes in demand and adjust business development strategies. Identify ongoing potential projects across regions. How is our ‘Automated Homes’ report different from other reports in the market? The report presents in-depth market sizing information...
-
Product Insights
Rotavirus Infections – Drugs In Development, 2023
Global Markets Direct’s, ‘Rotavirus Infections - Drugs In Development, 2023’, provides an overview of the Rotavirus Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Rotavirus Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Severe Acute Respiratory Syndrome (SARS) – Drugs In Development, 2023
Global Markets Direct’s, ‘Severe Acute Respiratory Syndrome (SARS) - Drugs In Development, 2023’, provides an overview of the Severe Acute Respiratory Syndrome (SARS) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Severe Acute Respiratory Syndrome (SARS), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
Chagas Disease (American Trypanosomiasis) – Drugs In Development, 2023
Global Markets Direct’s, ‘Chagas Disease (American Trypanosomiasis) - Drugs In Development, 2023’, provides an overview of the Chagas Disease (American Trypanosomiasis) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Chagas Disease (American Trypanosomiasis), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BNT-165e in Malaria
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BNT-165e in Malaria report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BNT-165e in Malaria Drug Details: BNT165e is under development for the prevention of...